Karolinska Development AB Stock
Equities
KDEV
SE0002190926
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.55 SEK | +2.11% | +2.11% | -8.72% |
Sales 2024 * | 2M 183K | Sales 2025 * | 2M 183K | Capitalization | 410M 37.43M |
---|---|---|---|---|---|
Net income 2024 * | -17M -1.55M | Net income 2025 * | -16M -1.46M | EV / Sales 2024 * | 175 x |
Net cash position 2024 * | 59M 5.39M | Net cash position 2025 * | 42M 3.84M | EV / Sales 2025 * | 184 x |
P/E ratio 2024 * |
-25.3
x | P/E ratio 2025 * |
-25.3
x | Employees | 8 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 35.96% |
1 day | +2.11% | ||
1 week | +2.11% | ||
Current month | +0.13% | ||
1 month | +0.78% | ||
3 months | -11.23% | ||
6 months | +6.02% | ||
Current year | -8.72% |
Managers | Title | Age | Since |
---|---|---|---|
Viktor Drvota
CEO | Chief Executive Officer | 59 | 15-12-06 |
Director of Finance/CFO | 56 | 22-09-30 | |
John Öhd
CTO | Chief Tech/Sci/R&D Officer | 53 | 20-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Björn Cochlovius
CHM | Chairman | 56 | 19-12-31 |
Viktor Drvota
CEO | Chief Executive Officer | 59 | 15-12-06 |
Director/Board Member | 55 | 21-02-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.55 | +2.11% | 138 027 |
24-04-25 | 1.518 | -2.06% | 83,626 |
24-04-24 | 1.55 | +1.31% | 54,504 |
24-04-23 | 1.53 | +1.59% | 53,492 |
24-04-22 | 1.506 | -0.79% | 185,398 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 11:07 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.72% | 37.56M | |
-2.41% | 185B | |
-3.90% | 105B | |
-5.19% | 66.59B | |
+3.52% | 54.66B | |
+16.62% | 47.78B | |
+4.06% | 41.26B | |
+2.85% | 26.95B | |
+3.01% | 26.37B | |
+12.96% | 24.8B |
- Stock Market
- Equities
- KDEV Stock